ATP13A2 and Parkinson disease: Moreover, the efficiency of this pathway is dependent on the astrocytic function of ATP13A2 [58], mutations of which are linked to autosomal recessive PD pathology, supporting the role of ATP13A2 in astrocytic lysosomal degradation of α-synuclein aggregates.